Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Verheijen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Trends in Pharmacological Sciences|July 20, 2001
Insurmountable AT(1) receptor antagonism: the need for different antagonist binding states of the receptorG Vauquelin, F Fierens, I Verheijen, et al.
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 24, 2004
AT1 receptor antagonistsI Verheijen, P M L Vanderheyden, J P De Backer, et al.
Pharmaceutical Research|April 17, 2001
Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT1 receptorsP M Vanderheyden, I Verheijen, F L Fierens, et al.
Fundamental & Clinical Pharmacology|February 24, 2001
Interaction between the partially insurmountable antagonist valsartan and human recombinant angiotensin II type 1 receptorsI Verheijen, F L Fierens, J P Debacker, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|April 23, 2002
Binding characteristics of [(3)H]-irbesartan to human recombinant angiotensin type 1 receptorsP M Vanderheyden, I Verheijen, F L Fierens, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Trends in Pharmacological Sciences|July 20, 2001
Insurmountable AT(1) receptor antagonism: the need for different antagonist binding states of the receptorG Vauquelin, F Fierens, I Verheijen, et al.
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 24, 2004
AT1 receptor antagonistsI Verheijen, P M L Vanderheyden, J P De Backer, et al.
Pharmaceutical Research|April 17, 2001
Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT1 receptorsP M Vanderheyden, I Verheijen, F L Fierens, et al.
Fundamental & Clinical Pharmacology|February 24, 2001
Interaction between the partially insurmountable antagonist valsartan and human recombinant angiotensin II type 1 receptorsI Verheijen, F L Fierens, J P Debacker, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|April 23, 2002
Binding characteristics of [(3)H]-irbesartan to human recombinant angiotensin type 1 receptorsP M Vanderheyden, I Verheijen, F L Fierens, et al.
Pageof 1